Investment Summary |
|
|---|---|
| Date | 2022-02-07 |
| Target | Reliance Health |
| Sector | Healthcare Services |
| Investor(s) | General Atlantic |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1980 |
| PE ASSETS | 105.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
General Atlantic is a large private equity firm that invests globally in growth-oriented public and private companies. Broad areas of interest include financial services, media and consumer, healthcare, enterprise solutions, communications and electronics, and energy. General Atlantic looks to invest $40 to $400 million in transactions that support growth, expansions, buy-outs, consolidations and build-ups. General Atlantic seeks to make 8 to 12 investments per year with an investment horizon of five to ten years. The Firm's geographic coverage spans North America; Europe; Asia/Pacific; and India. General Atlantic was formed in 1980 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 318 of 364 |
| Sector: Healthcare Services M&A | 20 of 25 |
| Type: Venture M&A Deals | 92 of 98 |
| Country: Nigeria M&A | 1 of 1 |
| Year: 2022 M&A | 8 of 24 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-03 |
Bold
Bogota, Colombia Bold is an emerging independent merchant-acquirer with the mission of promoting financial inclusion by expanding the digital payments ecosystem in Colombia. Bold was founded in 2019 and is based in Bogota, Colombia. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-16 |
Third Harmonic Bio
San Francisco, California, United States Third Harmonic Bio is a clinical stage bio technology company developing an oral KIT inhibitor therapy for allergic autoimmune disorders. Third Harmonic Bio was founded in 2019 and is based in San Francisco, California. |
Buy | - |
